Literature DB >> 12618052

Myoclonus and neurodegenerative disease--what's in a name?

John N Caviness1.   

Abstract

Myoclonus is a clinical symptom (or sign) defined as sudden, brief, shock-like, involuntary movements caused by muscular contractions or inhibitions. It may be classified by examination findings, etiology, or physiological characteristics. The main physiological categories for myocolonus are cortical, cortical-subcortical, subcortical, segmental, and peripheral. Neurodegenerative syndromes are potential causes of symptomatic myoclonus. Such syndromes include multiple system atrophy, corticobasal degeneration, progressive supranuclear palsy, frontotemporal dementia and parkinsonism linked to chromosome 17, Huntington's disease, dentato-rubro-pallido-luysian atrophy, Alzheimer's disease, and Parkinson's disease, and other Lewy body disorders. Each neurodegenerative syndrome can have overlapping as well as distinctive clinical neurophysiological properties. However, claims of differentiating between neurodegenerative disorders by using the presence or absence of small amplitude distal action myclonus appear unwarranted. When the myoclonus is small and repetitive, it may not be possible to distinguish it from tremor by phenotypic appearance alone. In this case, clinical neurophysiological offers an opportunity to provide greater differentiation of the phenomenon. More study of the myoclonus in neurodegenerative disease will lead to a better understanding of the processes that cause phenotypic variability among these disorders. Copyright 2003 Elsevier Science Ltd.

Entities:  

Mesh:

Year:  2003        PMID: 12618052     DOI: 10.1016/s1353-8020(02)00054-8

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  7 in total

Review 1.  Parkinson's disease dementia and potential therapeutic strategies.

Authors:  John N Caviness; LihFen Lue; Charles H Adler; Douglas G Walker
Journal:  CNS Neurosci Ther       Date:  2010-12-28       Impact factor: 5.243

Review 2.  Hashimoto's encephalopathy : epidemiology, pathogenesis and management.

Authors:  Ramon Mocellin; Mark Walterfang; Dennis Velakoulis
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

3.  Generalized myoclonus as a prominent symptom in a patient with FTLD-TDP.

Authors:  Martin Pail; Radoslav Matej; Ivica Husarova; Irena Rektorova
Journal:  J Neurol       Date:  2013-05-09       Impact factor: 4.849

Review 4.  Parkinsonism, movement disorders and genetics in frontotemporal dementia.

Authors:  José Fidel Baizabal-Carvallo; Joseph Jankovic
Journal:  Nat Rev Neurol       Date:  2016-02-19       Impact factor: 42.937

5.  Distinct MRI atrophy patterns in autopsy-proven Alzheimer's disease and frontotemporal lobar degeneration.

Authors:  G D Rabinovici; W W Seeley; E J Kim; M L Gorno-Tempini; K Rascovsky; T A Pagliaro; S C Allison; C Halabi; J H Kramer; J K Johnson; M W Weiner; M S Forman; J Q Trojanowski; S J Dearmond; B L Miller; H J Rosen
Journal:  Am J Alzheimers Dis Other Demen       Date:  2007 Dec-2008 Jan       Impact factor: 2.035

6.  A retrospective study of the clinical and electrophysiological characteristics of 32 patients with orthostatic myoclonus.

Authors:  J A van Gerpen
Journal:  Parkinsonism Relat Disord       Date:  2014-05-22       Impact factor: 4.891

7.  Memantine-induced Myoclonus in a Patient with Alzheimer Disease.

Authors:  Aditya A Murgai; Mark S LeDoux
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2015-08-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.